programma definitivo - Società italiana di neurologia
programma definitivo - Società italiana di neurologia
programma definitivo - Società italiana di neurologia
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
4<br />
N<br />
O<br />
V<br />
E<br />
M<br />
B<br />
R<br />
E<br />
•<br />
A<br />
R<br />
E<br />
A<br />
P<br />
O<br />
S<br />
T<br />
E<br />
R<br />
496. FIVE-YEAR EDSS DISABILITY AFTER THE FIRST DEMYELINATING<br />
EPISODE (CLINICALLY ISOLATED SYNDROME): THE GERONIMUS<br />
PROSPECTIVE COHORT<br />
R. D’ALESSANDRO, E. BALDIN, M. BENEDETTI, M. GALEOTTI, F. GRANELLA, M. LEONE,<br />
A. LUGARESI, S. MALAGU’, E. MONTANARI, L. MOTTI, W. NERI, M. SANTANGELO, C.<br />
SCANDELLARI, M. TOLA, L. VIGNATELLI, - ON BEHALF OF THE GERONIMUS STUDY<br />
GROUP (Bologna, New York - USA, Verona, Lugo <strong>di</strong> Romagna - RA, Parma, Novara,<br />
Chieti, Cesena, Fidenza - PR, Reggio Emilia, Forlì - FC, Carpi - MO, Ferrara)<br />
497. THE “FRAILTY” OF MULTIPLE SCLEROSIS AND ITS EFFECT ON SOCIAL<br />
AND HEALTHCARE COST BURDEN: THE EXPERIENCE OF FERRARA,<br />
ITALY<br />
E. BALDI, V. TOZZI, G. PACILEO, N. NAPOLI, L. CANIATTI, S. BIANCHI, G. ROVERSI,<br />
R. TOLA (Ferrara, Milano)<br />
498. TAPENTADOL FOR TREATING PAIN IN MULTIPLE SCLEROSIS PATIENTS<br />
C. SOLARO, E. TRABUCCO, M. CELLA, P. TANGANELLI (Genova)<br />
499. UPPER LIMB FUNCTION AFTER FAMPRIDINE TREATMENT: AN OPEN<br />
MULTICENTER LABEL STUDY<br />
C. SOLARO, E. TRABUCCO, D. CATTANEO, M. CELLA, P. TANGANELLI, M. ROVARIS<br />
(Genova, Milano)<br />
500. TRANSCRANIAL DIRECT CURRENT STIMULATION OF MOTOR CORTEX<br />
DOES NOT AMELIORATES SPASTICITY IN MULTIPLE SCLEROSIS<br />
R. IODICE, F. MANGANELLI, L. RUGGIERO, R. DUBBIOSO, S. MONTELLA, P. CARRIERI,<br />
L. SANTORO (Napoli)<br />
501. ROLE OF BETA INTERFERON IN MYCOBACTERIUM AVIUM SUBSPECIES<br />
PARATUBERCOLOSIS ANTIBODIES RESPONSE IN MS SARDINIAN<br />
PATIENTS<br />
J. FRAU, D. COSSU, G. COGHE, L. LOREFICE, G. FENU, M. MELIS, G. PORCU, M.<br />
MURRU, S. TRANQUILLI, M. MARROSU, L. SECHI, E. COCCO (Cagliari, Sassari)<br />
502. IS FINGOLIMOD DISCONTINUATION NECESSARY AFTER ASYMPTOMATIC<br />
LYMPHOCYTOPENIA A CASE REPORT<br />
V. PRONE, R. MARAZZI, L. LA MANTIA, C. ERMINIO, L. DE TONI FRANCESCHINI, F.<br />
IMBESI, E. AGOSTONI, A. PROTTI (Milano)<br />
503. FAMPRIDINE IS EFFECTIVE ON WALKING ABILITY IN A SUBGROUP OF<br />
MULTIPLE SCLEROSIS PATIENTS<br />
C. SOLARO, E. TRABUCCO, M. CELLA, P. TANGANELLI (Genova)<br />
504. ORAL FAMPRIDINE IMPROVES STANDING BALANCE DETECTED AT<br />
STATIC POSTUROGRAPHY IN MULTIPLE SCLEROSIS<br />
L. PROSPERINI, C. GIANNÌ, D. FORTUNA, M. MARCHETTI, C. POZZILLI (Roma)<br />
505. A TOLL-FREE HELPLINE DEDICATED TO MULTIPLE SCLEROSIS: PATIENTS’<br />
SATISFACTION AND IMPACT ON HEALTHCARE PROVIDERS<br />
L. PROSPERINI, V. BIANCHI, I. LUZI, G. BORRIELLO, C. POZZILLI (Roma)<br />
506. GAIT INITIATION EVALUATION IN MULTIPLE SCLEROSIS<br />
G. COGHE, M. GALLI, M. PAU, J. FRAU, L. LOREFICE, G. FENU, M. MELIS, M. MARROSU,<br />
E. COCCO (Cagliari, Milano)<br />
507. PATHOPHYSIOLOGY OF TISSUE DAMAGE IN PROGRESSIVE MULTIPLE<br />
SCLEROSIS: AN IMMUNOLOGICAL AND MRI COMPARATIVE STUDY<br />
VERSUS MOTOR NEURON DISEASE<br />
P. TORTORELLA, M. LAGANÀ, M. SARESELLA, L. GRIFFANTI, E. TAVAZZI, I. MARVENTANO,<br />
G. PINARDI, M. CORBO, C. LUNETTA, P. CECCONI, D. CAPUTO, M. CLERICI, M.<br />
ROVARIS (Milano)<br />
170
Change language